Galmed Share Price

Galmed Share Price

NASDAQ: GLMD | Healthcare
$0.00
+0.00 (0.00%)
  • Performance
  • Chart
  • Fundamentals
  • Profit & Loss
  • Balance Sheet
  • Cash Flow
  • Corporate Actions
  • About
  • Price history
  • FAQs

Galmed Stock Performance

Open
N/A
Prev. Close
N/A
Circuit Range
N/A
Day Range
N/A
Year Range
N/A
Volume
N/A
Average Traded
N/A

Galmed Share Price Chart

$0.00$0.00
L
Show Current Price
H

Galmed Stock Fundamentals & Key Indicators

Market Cap
N/A
PE Ratio (TTM)
N/A
Dividend Yield
N/A
EPS (TTM)
N/A
Revenue (TTM)
$0.00
Return On Equity (TTM)
N/A
Profit Margin
N/A
Debt to Equity
N/A
Quarterly Earnings Growth YoY
N/A

Galmed Annual Profit & Loss

All figures in USD

Particulars2022202320242025
Revenue$0.00$0.00$0.00$0.00
Net Profit-$17.87-$6.91-$7.52-$10.31
Net Profit MarginN/AN/AN/AN/A
Income ChangeN/A61.33%-8.83%-37.10%

Galmed Balance Sheet

All figures in USD Million

Particulars2025202420232022
Non Current Assets0.02.383.391.84
Current Assets18.6316.1213.2414.72
Total Assets18.6318.516.6316.56
Non Current Liabilities0.00.00.00.04
Current Liabilities2.852.172.753.09
Total Liabilities2.852.172.753.14
Shareholders' Equity15.7816.3313.8813.42

Galmed Cash Flow

Annually

All figures in USD Million

Particulars2025202420232022
Operating-6.32-5.88-6.14-18.5
Investing-3.38-1.110.817.56
Financing9.038.796.190.07

Corporate Actions

Split
Ex-date: 19 Aug 2026

Split
Ex-date: 30 Aug 2024

Split
Ex-date: 15 May 2023

About Galmed

Galmed Pharmaceuticals Ltd is a biopharmaceutical company. The company focuses on the development of Aramchol for combination therapy for GI oncological indications. The company is actively pursuing opportunities in the biotech and medtech spaces to expand and diversify its product pipeline targeting GI, cardiometabolic indications and other product candidates.

Galmed Historical Returns

Share price history by day, with open and close prices and the day's change
MonthOpenCloseChange %

Galmed Share Price FAQs